PRESENTATION

Q4 2022 — Presentation

Q4 2022PDF · 39 pages1.3 MB
GE fourth quarter & full year 2022
performance
Financial results & company highlights
January 24, 2023
CAUTION CONCERNING FORWARD-LOOKING STATEMENTS:
This document contains "forward-looking statements" – that is, statements related to future events that by their nature address matters that are, to different degrees, uncertain. For details on the uncertainties that may cause
our actual future results to be materially different than those expressed in our forward-looking statements, see https://www.ge.com/investor-relations/important-forward-looking-statement-information as well as our annual
reports on Form 10-K and quarterly reports on Form 10-Q. We do not undertake to update our forward-looking statements. This document also includes certain forward-looking projected financial information that is based on
current estimates and forecasts. Actual results could differ materially.
NON-GAAP FINANCIAL MEASURES:
In this document, we sometimes use information derived from consolidated financial data but not presented in our financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP).
Certain of these data are considered “non-GAAP financial measures” under the U.S. Securities and Exchange Commission rules. These non-GAAP financial measures supplement our GAAP disclosures and should not be
considered an alternative to the GAAP measure. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in our earnings
release and the appendix of this presentation and prior earnings presentations, as applicable.
Amounts shown on subsequent pages may not add due to rounding. Unless otherwise stated, these financial results are shown including GE HealthCare in continuing operations as of December 31, 2022.
GE’s Investor Relations website at www.ge.com/investor and our corporate blog at www.gereports.com, as well as GE’s Facebook page and Twitter accounts, contain a significant amount of information about GE, including
financial and other information for investors. GE encourages investors to visit these websites from time to time, as information is updated and new information is posted.

-- 1 of 39 --

A new era begins ...
Strong 4Q finish
& successful
GE HealthCare spin
Strong
GE Aerospace
results
GE Vernova: improving with
Power delivering &
Renewable Energy taking action

-- 2 of 39 --

2022 snapshot
Adjusted revenue*
FY'22
Adjusted profit margin*
Adjusted EPS*
Free cash flow*
Orders
GE, including GE HealthCare
Significant growth, margin, EPS & FCF* improvement
3
4Q'22
+18%
+11%
+290 bps
$4.3B
$1.24
+7%
+6%
+160 bps
$4.8B
$2.62 	+$0.91, +53%
+$2.1B-b), +81%
* Non-GAAP Financial Measure
(a– Year-over-year variances for orders, revenue and margin are presented on an organic basis
(b– Excludes prior period CFOA impact from discontinued factoring programs
$25.4B
$21.0B
10.3%
+$0.42, +51%
+$0.6B, +16%
$83.0B
$73.6B
7.9%
Y/Y VARIANCE-a)RESULTS 	Y/Y VARIANCE-a)RESULTS

-- 3 of 39 --

• Orders: $9.7B, +26% … Commercial Services & Military
equipment
• Revenue: $7.6B, +26% * ... services, notably
Commercial, & equipment from higher LEAP engine
deliveries
• Margin: 18.8%, (150)bps * ... volume & price offsetting
negative engine mix, investment & other costs
* Non-GAAP Financial Measure
(a– Year-over-year variances for orders, revenue and margin are presented on an organic basis
(b– Excludes prior period CFOA impact from discontinued factoring programs
4Q'22 RESULTS 	4Q'22 DYNAMICS-a)
GE Aerospace
($ in billions)
Rev. Growthorg* 	4% 	12% 	27% 	25% 	26%
Profit $ 	1.2 	0.9 	1.1 	1.3 	1.4
4
FY'23 OUTLOOK
• Organic revenue growth*: mid to high teens
• Operating profit: $5.3B-$5.7B
• FCF*: up; earnings & W/C partially offset by ~$(0.5)B AD&A
• FY'22 FCF*: $4.9B … earnings & W/C; +$0.3B -b) y/y

-- 4 of 39 --

• Orders: $5.0B, +7% ... equipment growth from Grid &
Onshore in North America
• Revenue: $3.4B, (13)%* … lower Onshore deliveries
• Margin: (13.3)%, (260)bps * … Grid improvement offset by
Onshore volume pressure & inflation across businesses
• FY'22 FCF*: $(2.0)B ... earnings; $(0.8)B -b) y/y
2Q21	2Q20
($ in billions)
4Q'22 RESULTS 	4Q'22 DYNAMICS-a)
Rev. Growthorg* 	(5)% 	(10)% 	(20)% 	(10)% 	(13)%
Profit $ 	(0.3) 	(0.4) 	(0.4) 	(0.9) 	(0.5)
Renewable Energy
part of GE Vernova, GE's portfolio of energy businesses
5
• Organic revenue growth*: +MSD
• Operating profit: significantly better
• FCF*: flat to improving; earnings growth with flat W/C
* Non-GAAP Financial Measure
(a– Year-over-year variances for orders, revenue and margin are presented on an organic basis
(b– Excludes prior period CFOA impact from discontinued factoring programs
FY'23 OUTLOOK

-- 5 of 39 --

• Orders: $5.4B, +29% … higher Aeroderivatives
equipment & transactional services growth
• Revenue: $5.0B, +12% * ... Aeroderivative equipment
& total services growth
• Margin: 13.8%, +710bps * … higher volume, better
price/cost & productivity
• FY'22 FCF*: $1.9B ... earnings & W/C; +$0.7B -b) y/y
2Q21	2Q20
Power
part of GE Vernova, GE's portfolio of energy businesses
4Q'22 RESULTS 	4Q'22 DYNAMICS-a)
Rev. Growthorg* (10)
% (6)% 	4% 	(5)% 	12%
Profit $ 	0.3 	0.1 	0.3 	0.1 	0.7
($ in billions)
6
• Organic revenue growth*: +LSD
• Operating profit: slightly better
• FCF*: lower; earnings growth offset by disbursements
* Non-GAAP Financial Measure
(a– Year-over-year variances for orders, revenue and margin are presented on an organic basis
(b– Excludes prior period CFOA impact from discontinued factoring programs
FY'23 OUTLOOK

-- 6 of 39 --

FY 2023 Outlook
Confident in strong market demand & operational improvements across businesses
GE AEROSPACE
Mid-to-high teens growth, $5.3B-$5.7B profit, FCF*
up
• 	High-teens to ~20% Commercial Services & ~20%
engines growth, +HSD Military growth
• 	Profit: volume, price + productivity > mix + inflation
• 	Mix pressuring margin rate
7
GE, excluding GE HealthCare
GE VERNOVA -a)
LSD to MSD growth, $(0.6)B-$(0.2)B profit, FCF* flat
to slightly improved
• 	Renewable Energy: Onshore better... price & cost
actions, large 2H down payments; Offshore growth
• 	Power: Gas outage volume higher; Gas equipment
growth; profit: volume, productivity + price > inflation
2023
OUTLOOK
Adjusted EPS* 	$0.77
Free cash flow* 	$3.1B
Organic revenue growth* 	+6%
2022
EX-GEHC
+HSD
$3.4B-$4.2B
$1.60-$2.00
* Non-GAAP Financial Measure
Revenue assumptions on organic basis.
'22 GE excluding HealthCare: Adjusted revenues* $55.1B, Adjusted profit* $3.2B, Adjusted profit margin* 5.7%
Expect '23 interest expense ~$(1)B, adjusted tax rate* mid-20s; adjusted corporate cost* ~flat, corporate FCF* significantly better
(a– For the purposes of 2023 Outlook, GE Vernova refers to the sum of our Renewable Energy and Power segments, without giving effect to eliminations and Corporate adjustments.

-- 7 of 39 --

Building momentum toward independent industry leaders
8
Driving continued
growth in 2023
GE Aerospace
executing on ramp with
significant profit growth
Leading in critical growth sectors ... Future of Flight & Energy Transition
GE Vernova
making progress &
preparing to spin

-- 8 of 39 --

Q&A
9
CFM signed an agreement for Air
France KLM Engineering &
Maintenance to provide the full
scope of LEAP MRO services for
operators worldwide
Gas Power secured an order
from the Swiss Federal Office of
Energy, renting eight mobile
aeroderivative gas turbine units to
help meet electricity demand
during the critical period near end
of winter

-- 9 of 39 --

Appendix
11 	HealthCare Operating segment results
12 	TY Operating segment results
13 	Orders $
14 	Backlog $
15 	Revenue $
16 	Orders and Sales units
17 	FCF
18 	FCF details
10

-- 10 of 39 --

GE HealthCare (NASDAQ: GEHC) spun off from GE on
January 3, 2023 and is now a standalone company that
will release its financial results in connection with their
earnings call on January 30, 2023.
2Q21	2Q20
GE HealthCare
($ in billions)
4Q'22 RESULTS (GE basis)
* Non-GAAP Financial Measure
Rev. Growthorg* 	(4)% 	2% 	4% 	10% 	12%
Profit $ 	0.8 	0.5 	0.7 	0.7 	0.8
11

-- 11 of 39 --

HEALTHCARE
(GE basis)	RENEWABLES
2022 Operating segments results
POWER	AEROSPACE
* Non-GAAP Financial Measure
(a– Excludes prior period CFOA impact from discontinued factoring programs
$ / % y/y
(org.)* 	$ / % y/y
(org.)* 	$ / % y/y
(org.)* 	$ / % y/y
(org.)*
Orders 	$31.1 	22% 	$14.7 	(17)% 	$17.8 	13% 	$19.9 	4%
Revenue 	$26.0 	23% 	$13.0 	(13)% 	$16.3 	2% 	$18.5 	7%
Segment
profit $4.8 	62% 	$(2.2) 	U 	$1.2 	69% 	$2.7 	(2)%
Segment
margin 18.3% 	440bps 	(17.3)% 	(1,150)bps 	7.5% 	300bps 	14.7% 	(150)bps
FCF* -a) 	$4.9 	$0.3 	$(2.0) 	$(0.8) 	$1.9 	$0.7 	$2.1 	$(0.6)
12
($ in billions)
GE results, including GE HealthCare

-- 12 of 39 --

Orders - supplemental information
4Q'22 y/y
(org.) FY'22 y/y
(org.) 4Q'22 y/y
(org.) FY'22 y/y
(org.) 4Q'22 y/y
(org.) FY'22 y/y
(org.)
Aerospace 	$4.4 	48% 	$11.4 	17% 	$5.3 	12% 	$19.7 	25% 	$9.7 	26% 	$31.1 	22%
Renewable Energy 	$4.5 	12% 	$12.3 	(17)% 	$0.5 	(23)% 	$2.4 	(20)% 	$5.0 	7% 	$14.7 	(17)%
Power 	$1.7 	57% 	$5.5 	29% 	$3.7 	20% 	$12.4 	6% 	$5.4 	29% 	$17.8 	13%
HealthCare 	$3.1 	2% 	$11.2 	3% 	$2.2 	8% 	$8.6 	7% 	$5.3 	5% 	$19.9 	4%
Total Company 	$13.6 	24% 	$39.9 	1% 	$11.8 	11% 	$43.1 	12% 	$25.4 	18% 	$83.0 	7%
EQUIPMENT ORDERS 	SERVICE ORDERS 	TOTAL ORDERS
13
($ in billions)
GE results, including GE HealthCare

-- 13 of 39 --

4Q'22 	y/y 	4Q'22 	y/y 	4Q'22 	y/y
Aerospace 	$39.7 	9% 	$312.9 	17% 	$352.6 	16%
Renewable Energy 	$20.1 	8% 	$12.7 	(1)% 	$32.8 	4%
Power 	$13.4 	(6)% 	$60.9 	2% 	$74.3 	—%
HealthCare 	$7.2 	12% 	$11.7 	(8)% 	$18.9 	(1)%
Total Company 	$79.3 	6% 	$399.0 	13% 	$478.2 	12%
14
Backlog - supplemental information
($ in billions)
GE results, including GE HealthCare
EQUIPMENT BACKLOG 	SERVICE BACKLOG 	TOTAL BACKLOG

-- 14 of 39 --

Revenues - supplemental information
4Q'22 y/y
(org.)* FY'22 y/y
(org.)* 4Q'22 y/y
(org.)* FY'22 y/y
(org.)* 4Q'22 y/y
(org.)* FY'22 y/y
(org.)*
Aerospace 	$2.5 	26% 	$7.8 	5% 	$5.2 	26% 	$18.2 	32% 	$7.6 	26% 	$26.0 	23%
Renewable Energy 	$2.7 	(14)% 	$10.2 	(19)% 	$0.7 	(7)% 	$2.8 	15% 	$3.4 	(13)% 	$13.0 	(13)%
Power 	$1.6 	27% 	$4.7 	—% 	$3.4 	6% 	$11.5 	3% 	$5.0 	12% 	$16.3 	2%
HealthCare 	$2.7 	16% 	$9.6 	8% 	$2.3 	8% 	$8.8 	6% 	$5.0 	12% 	$18.5 	7%
Total Company 	$9.4 	9% 	$32.0 	(4)% 	$11.6 	13% 	$41.6 	16% 	$21.0 	11% 	$73.6 	6%
* Non-GAAP Financial Measure
(a– Adjusted revenues* (Total revenues less Insurance)
-a)*
15
EQUIPMENT REVENUES 	SERVICE REVENUES 	TOTAL REVENUES
($ in billions)
GE results, including GE HealthCare
-a)*

-- 15 of 39 --

Orders and Sales - supplemental information, units
(a– LEAP engines are a subset of Commercial Engines
(b– Includes Onshore and Offshore units
(c– Gigawatts reported associated with orders and sales in the periods presented
(d– Heavy-Duty Gas Turbines and Aeroderivatives are subsets of GE Gas Turbines
(e– HA-Turbines are a subset of Heavy-Duty Gas Turbines
(f– Commercial externally shipped spares and spares used in time & material shop visits in millions of dollars per day
(in units)
4Q'22 	4Q'21 	FY22 	FY21
Aerospace
Commercial Engines 	824 	977 	2,127 	2,248
LEAP Engines -a) 	579 	591 	1,515 	1,457
Military Engines 	373 	55 	532 	723
Renewable Energy
Wind Turbines-b) 	1,011 	645 	2,243 	2,860
Wind Turbine Gigawatts-b),-c) 	3.2 	3.1 	7.8 	12.1
Repower units 	— 	141 	411 	786
Power
GE Gas Turbines 	32 	27 	92 	123
Heavy-Duty Gas Turbines -d) 	13 	22 	30 	65
HA-Turbines -e) 	1 	4 	9 	10
Aeroderivatives -d) 	19 	5 	62 	58
GE Gas Turbine Gigawatts -c) 	2.9 	4.2 	9.8 	12.6
16
4Q'22 	4Q'21 	FY22 	FY21
Aerospace
Commercial Engines 	476 	368 	1,663 	1,487
LEAP Engines -a) 	324 	220 	1,136 	845
Military Engines 	166 	148 	632 	553
Spares rate -f) ($ in millions) 	31.9 	23.8 	26.9 	17.8
Renewable Energy
Wind Turbines-b) 	487 	842 	2,190 	3,590
Wind Turbine Gigawatts -b),-c) 	1.8 	2.8 	7.5 	11.7
Repower units 	165 	285 	580 	561
Power
GE Gas Turbines 	32 	15 	101 	62
Heavy-Duty Gas Turbines -d) 	16 	9 	53 	43
HA-Turbines-e) 	5 	2 	11 	13
Aeroderivatives -d) 	16 	6 	48 	19
ORDERS 	SALES

-- 16 of 39 --

• 	Positive contribution from earnings & working capital … y/y
improvement from earnings and debt reduction
• 	$4.9B Aerospace … +$0.3B y/y driven by earnings growth
offsetting working capital and AD&A pressure
• 	$(2.0)B Renewables … $(0.8)B y/y due to lower earnings
• 	$1.9B Power ... +$0.7B y/y driven by Gas earnings growth,
services billings and Steam
• 	$2.1B HealthCare (GE basis) … $(0.6)B y/y driven by supply
chain challenges pressuring profit and working capital
• 	$(2.1)B Corporate, including $(1.4)B interest cash … +$2.6B
y/y driven by lower costs and debt reduction
Free cash flow* performance
* Non-GAAP Financial Measure
(a– Aggregates the following: Net earnings (loss) and (earnings) loss from discontinued operations
(b– Excludes CFOA impact from receivables factoring and supply chain finance eliminations in the prior year
(c– Includes the following: (Gains) losses on sales of business interests, (Gains) losses on equity securities, debt extinguishment costs, principal pension plans (net), other post retirement benefit plans (net), income
taxes (net), financial services derivatives and all other operating; excludes Insurance CFOA, separation cash expenditures, Corporate restructuring cash expenditures and deal taxes
(d– Excludes prior period CFOA impact from discontinued factoring programs
FY'22 DYNAMICS4Q'22 	y/y 	FY'22 	y/y
Net earnings (loss) -a) 	2.3 	5.8 	0.9 	4.3
Debt extinguishment costs 	0.5 	(4.6) 	0.5 	(6.1)
Depreciation & amortization 	0.7 	(0.0) 	3.5 	0.5
Operating working capital 	2.7 	0.4 	1.4 	0.1
Current receivables -b) 	(0.3) 	(1.0) 	(3.0) 	(5.2)
Inventory 	0.4 	(0.0) 	(2.3) 	(1.6)
Accounts payable -b) 	0.7 	0.5 	2.8 	2.9
Progress collections 	1.2 	0.7 	2.5 	3.5
Current contract assets 	0.7 	0.2 	1.5 	0.4
Other CFOA-b),-c) 	(1.5) 	(0.9) 	(0.1) 	4.1
Gross CAPEX 	(0.4) 	(0.1) 	(1.5) 	(0.1)
FCF* 	4.3 	0.6 	4.8 	2.9
FCF ex disc. factoring* -d) 	4.3 	0.6 	4.8 	2.1
($ in billions)
GE results, including GE HealthCare
17

-- 17 of 39 --

2022 Free cash flow* details
2022
1Q'22 	2Q'22 	3Q'22 	4Q'22 Total
Company Aerospace 	Renewables 	Power 	HealthCare 	Corporate
Net earnings (loss)-a) 	(0.7) 	(0.6) 	(0.1) 	2.3 	0.9 	3.9 	(2.2) 	0.9 	2.1 	(3.8)
Debt extinguishment costs — 	— 	— 	0.5 	0.5 	— 	— 	— 	— 	0.5
Depreciation & amortization 1.5 	0.7 	0.6 	0.7 	3.5 	1.0 	0.4 	0.5 	0.6 	0.9
Operating working capital (1.0) 	(0.2) 	(0.2) 	2.7 	1.4 	0.4 	0.0 	0.5 	(0.2) 	0.6
Other CFOA-b) 	(0.3) 	0.5 	1.1 	(1.5) 	(0.1) 	0.1 	0.0 	0.1 	(0.1) 	(0.3)
Gross capex (0.4) 	(0.3) 	(0.3) 	(0.4) 	(1.5) 	(0.6) 	(0.3) 	(0.2) 	(0.3) 	0.0
FCF* (0.9) 	0.2 	1.2 	4.3 	4.8 	4.9 	(2.0) 	1.9 	2.1 	(2.1)
* Non-GAAP Financial Measure
(a– Aggregates the following: Net earnings (loss) and (earnings) loss from discontinued operations
(b– Includes the following: (Gains) losses on sales of business interests, (Gains) losses on equity securities, debt extinguishment costs, principal pension plans (net), other post retirement benefit plans (net), income
taxes (net), financial services derivatives and all other operating; excludes Insurance CFOA, separation cash expenditures, Corporate restructuring cash expenditures and deal taxes
18
($ in billions)
GE results, including GE HealthCare

-- 18 of 39 --

Non-GAAP reconciliations
19
20 Organic revenues, profit (loss) & profit margin by segment
21 Organic revenues, including and excluding GE HealthCare
22 Organic revenues by sub segment
23 Equipment & service organic revenues
24 Equipment & service organic revenues by sub segment
25 Adjusted profit & profit margin
26 Adjusted profit & profit margin excluding GE HealthCare
27 Adjusted organic profit & profit margin
28 Adjusted earnings (loss) and Adjusted earnings (loss) per share
29 Adjusted earnings (loss) and Adjusted earnings (loss) per share excluding GE HealthCare
30 Adjusted income tax rate and Adjusted earnings from continuing operations before income taxes
31 Free cash flows (FCF) (including and excluding discontinued factoring) and Free cash flows (FCF) excluding GE HealthCare
32 Free cash flows (FCF) by quarter (incl and excl disc factoring)
33 Free cash flows (FCF) by segment (incl and excl disc factoring)
34 Adjusted Corporate costs
35 Net debt
36 Net debt excluding GE HealthCare
37 Leverage EBITDA & net debt/EBITDA ratio
38 Leverage EBTIDA & net debt/EBITDA ratio excluding GE HealthCare

-- 19 of 39 --

20
Organic revenues, profit (loss) and profit margin by segment
* Non-GAAP Financial Measure
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional
impacts, as these activities can obscure underlying trends.
ORGANIC REVENUES, PROFIT (LOSS) AND PROFIT MARGIN BY SEGMENT (NON-GAAP)
REVENUES 	PROFIT (LOSS) 	PROFIT MARGIN 	REVENUES 	PROFIT (LOSS) 	PROFIT MARGIN
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	4Q'22 	4Q'21 	V% 	4Q'22 	4Q'21 	V pts 	2022 	2021 	V% 	2022 	2021 	V% 	2022 	2021 	V pts
Aerospace (GAAP) 	$ 	7,615 $ 	6,080 	25 % 	$ 1,434 $ 1,218 	18 % 	18.8 % 20.0 % 	(1.2)pts 	$ 26,050 $ 21,310 	22 % 	$ 4,775 $ 2,882 	66 % 	18.3 % 13.5 % 	4.8pts
Less: acquisitions 	— 	— 	— 	— 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(29) 	(1) 	12 	(2) 	(80) 	— 	101 	3
Aerospace organic (Non-GAAP) 	$ 	7,645 $ 	6,082 	26 % 	$ 1,421 $ 1,221 	16 % 	18.6 % 20.1 % 	(1.5)pts 	$ 26,129 $ 21,311 	23 % 	$ 4,674 $ 2,879 	62 % 	17.9 % 13.5 % 	4.4pts
Renewable Energy (GAAP) 	$ 	3,413 $ 	4,192 	(19)% 	$ 	(454) $ 	(312) 	(46)% 	(13.3)% 	(7.4)% 	(5.9)pts 	$ 12,977 $ 15,697 	(17)% 	$ (2,240) $ 	(795) 	U 	(17.3)% 	(5.1)% (12.2)pts
Less: acquisitions 	— 	(12) 	— 	(4) 	— 	(55) 	— 	(17)
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(260) 	2 	(18) 	81 	(702) 	2 	55 	52
Renewable Energy organic (Non-
GAAP) 	$ 	3,673 $ 	4,202 	(13)% 	$ 	(435) $ 	(388) 	(12)% 	(11.8)% 	(9.2)% 	(2.6)pts 	$ 13,678 $ 15,749 	(13)% 	$ (2,295) $ 	(831) 	U 	(16.8)% 	(5.3)% (11.5)pts
Power (GAAP) 	$ 	5,030 $ 	4,661 	8 % 	$ 	692 $ 	309 	F 	13.8 % 	6.6 % 	7.2pts 	$ 16,262 $ 16,903 	(4)% 	$ 1,217 $ 	726 	68 % 	7.5 % 	4.3 % 	3.2pts
Less: acquisitions 	— 	— 	— 	— 	— 	— 	— 	—
Less: business dispositions 	— 	26 	— 	(2) 	— 	502 	— 	(2)
Less: foreign currency effect 	(182) 	(1) 	(54) 	(24) 	(503) 	(5) 	(78) 	(40)
Power organic (Non-GAAP) 	$ 	5,212 $ 	4,636 	12 % 	$ 	746 $ 	336 	F 	14.3 % 	7.2 % 	7.1pts 	$ 16,765 $ 16,405 	2 % 	$ 1,295 $ 	768 	69 % 	7.7 % 	4.7 % 	3.0pts
HealthCare (GAAP) 	$ 	4,966 $ 	4,625 	7 % 	$ 	804 $ 	762 	6 % 	16.2 % 16.5 % 	(0.3)pts 	$ 18,461 $ 17,725 	4 % 	$ 2,705 $ 2,966 	(9)% 	14.7 % 16.7 % 	(2.0)pts
Less: acquisitions 	63 	— 	2 	(11) 	238 	— 	(54) 	(16)
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(288) 	— 	(79) 	3 	(772) 	— 	(169) 	(14)
HealthCare organic (Non-GAAP) 	$ 	5,191 $ 	4,625 	12 % 	$ 	881 $ 	770 	14 % 	17.0 % 16.6 % 	0.4pts 	$ 18,994 $ 17,725 	7 % 	$ 2,928 $ 2,995 	(2)% 	15.4 % 16.9 % 	(1.5)pts

-- 20 of 39 --

21
Organic revenues and Organic revenues excluding GE HealthCare
ORGANIC REVENUES (NON-GAAP)
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Total revenues (GAAP) 	$ 	21,786 $ 	20,303 	7 % 	$ 	76,555 $ 	74,196 	3 %
Less: Insurance revenues 	775 	811 	2,954 	3,106
Adjusted revenues (Non-GAAP) 	$ 	21,011 $ 	19,492 	8 % 	$ 	73,602 $ 	71,090 	4 %
Less: acquisitions 	64 	(12) 	241 	(55)
Less: business dispositions 	— 	(21) 	— 	158
Less: foreign currency effect 	(765) 	— 	(2,079) 	(3)
Organic revenues (Non-GAAP) 	$ 	21,713 $ 	19,525 	11 % 	$ 	75,440 $ 	70,989 	6 %
ORGANIC REVENUES EXCLUDING GE HEALTHCARE (NON-GAAP)
(Dollars in millions) 	2022 	2021 	V%
Total revenues excluding GE HealthCare (GAAP) 	$ 	58,096 $ 	56,474 	3 %
Less: Insurance revenues 	2,954 	3,106
Adjusted revenues excluding GE HealthCare (Non-GAAP) 	$ 	55,143 $ 	53,368 	3 %
Less: acquisitions 	2 	(55)
Less: business dispositions 	— 	158
Less: foreign currency effect 	(1,307) 	(2)
Organic revenues excluding GE HealthCare (Non-GAAP) 	$ 	56,448 $ 	53,267 	6 %
* Non-GAAP Financial Measure
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of revenues from our run-off Insurance business, acquisitions, dispositions and foreign currency, which
includes translational and transactional impacts, as these activities can obscure underlying trends. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023.

-- 21 of 39 --

22
Organic revenues by sub segment
ORGANIC REVENUES BY SUB SEGMENT (NON-GAAP)
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Aerospace commercial services revenues (GAAP) 	$ 	3,680 $ 	2,864 	28 % 	$ 	12,858 $ 	8,995 	43 %
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	—
Less: foreign currency effect 	— 	— 	— 	—
Aerospace commercial services organic revenues (Non-GAAP) 	$ 	3,680 $ 	2,864 	28 % 	$ 	12,858 $ 	8,995 	43 %
Aerospace commercial engines revenues (GAAP) 	$ 	1,855 $ 	1,425 	30 % 	$ 	5,807 $ 	5,365 	8 %
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	—
Less: foreign currency effect 	— 	— 	— 	—
Aerospace commercial engines organic revenues (Non-GAAP) 	$ 	1,855 $ 	1,425 	30 % 	$ 	5,807 $ 	5,365 	8 %
Aerospace military revenues (GAAP) 	$ 	1,251 $ 	1,032 	21 % 	$ 	4,410 $ 	4,136 	7 %
Less: acquisitions 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	—
Less: foreign currency effect 	— 	— 	— 	—
Aerospace military organic revenues (Non-GAAP) 	$ 	1,251 $ 	1,032 	21 % 	$ 	4,410 $ 	4,136 	7 %
* Non-GAAP Financial Measure
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional
impacts, as these activities can obscure underlying trends.

-- 22 of 39 --

23
Equipment & service organic revenues
EQUIPMENT AND SERVICES ORGANIC REVENUES
(NON-GAAP) 	EQUIPMENT 	SERVICES
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V% 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Aerospace revenues (GAAP) 	$ 	2,463 $ 	1,982 	24 % 	$ 	7,842 $ 	7,531 	4 % 	$ 	5,152 $ 	4,099 	26 % 	$ 	18,207 $ 	13,780 	32 %
Less: acquisitions 	— 	— 	— 	— 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(28) 	— 	(43) 	— 	(1) 	(1) 	(36) 	—
Aerospace organic revenues (Non-GAAP) 	$ 	2,491 $ 	1,982 	26% 	$ 	7,885 $ 	7,531 	5% 	$ 	5,153 $ 	4,099 	26% $ 	18,244 $ 	13,780 	32%
Renewable Energy revenues (GAAP) 	$ 	2,686 $ 	3,380 	(21)% 	$ 	10,191 $ 	13,224 	(23)% 	$ 	727 $ 	812 	(10)% 	$ 	2,785 $ 	2,473 	13 %
Less: acquisitions 	— 	— 	— 	— 	— 	(12) 	— 	(55)
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(216) 	2 	(579) 	2 	(43) 	— 	(123) 	—
Renewable Energy organic revenues (Non-GAAP) 	$ 	2,903 $ 	3,378 	(14)% 	$ 	10,771 $ 	13,222 	(19)% 	$ 	770 $ 	824 	(7)% 	$ 	2,908 $ 	2,527 	15 %
Power revenues (GAAP) 	$ 	1,621 $ 	1,354 	20 % 	$ 	4,737 $ 	5,035 	(6)% 	$ 	3,409 $ 	3,307 	3 % 	$ 	11,526 $ 	11,868 	(3)%
Less: acquisitions 	— 	— 	— 	— 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	— 	— 	26 	— 	502
Less: foreign currency effect 	(103) 	— 	(275) 	(2) 	(79) 	— 	(228) 	(2)
Power organic revenues (Non-GAAP) 	$ 	1,725 $ 	1,355 	27 % 	$ 	5,012 $ 	5,037 	— % 	$ 	3,487 $ 	3,281 	6 % 	$ 	11,754 $ 	11,368 	3 %
HealthCare revenues (GAAP) 	$ 	2,698 $ 	2,434 	11 % 	$ 	9,643 $ 	9,104 	6 % 	$ 	2,269 $ 	2,191 	4 % 	$ 	8,818 $ 	8,620 	2 %
Less: acquisitions 	33 	— 	207 	— 	30 	— 	31 	—
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(154) 	— 	(400) 	— 	(134) 	— 	(372) 	—
HealthCare organic revenues (Non-GAAP) 	$ 	2,818 $ 	2,434 	16 % 	$ 	9,836 $ 	9,105 	8 % 	$ 	2,373 $ 	2,191 	8 % 	$ 	9,158 $ 	8,620 	6 %
Total revenues (GAAP) 	$ 	9,427 $ 	9,029 	4 % 	$ 	31,976 $ 	34,200 	(7)% 	$ 	11,584 $ 	10,464 	11 % 	$ 	41,626 $ 	36,890 	13 %
Less: acquisitions 	33 	— 	207 	— 	30 	(12) 	34 	(55)
Less: business dispositions 	— 	(32) 	— 	(177) 	— 	11 	— 	336
Less: foreign currency effect 	(508) 	1 	(1,319) 	— 	(257) 	(1) 	(760) 	(2)
Total organic revenues (Non-GAAP) 	$ 	9,901 $ 	9,059 	9 % 	$ 	33,088 $ 	34,378 	(4)% 	$ 	11,811 $ 	10,466 	13 % 	$ 	42,352 $ 	36,612 	16 %
* Non-GAAP Financial Measure
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional
impacts, as these activities can obscure underlying trends.

-- 23 of 39 --

24
Equipment & service organic revenues by sub segment
EQUIPMENT AND SERVICES ORGANIC REVENUES BY SUB
SEGMENT (NON-GAAP) 	EQUIPMENT 	SERVICES
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V% 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Gas Power revenues (GAAP) 	$ 	1,241 $ 	850 	46 % 	$ 	3,460 $ 	3,220 	7 % 	$ 	2,597 $ 	2,491 	4 % 	$ 	8,612 $ 	8,860 	(3)%
Less: acquisitions 	— 	— 	— 	— 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	— 	— 	26 	— 	502
Less: foreign currency effect 	(62) 	(1) 	(151) 	(3) 	(16) 	(1) 	(53) 	(3)
Gas Power organic revenues (Non-GAAP) 	$ 	1,304 $ 	851 	53 % 	$ 	3,611 $ 	3,223 	12 % 	$ 	2,613 $ 	2,465 	6 % 	$ 	8,665 $ 	8,360 	4 %
Steam Power revenues (GAAP) 	$ 	261 $ 	373 	(30)% 	$ 	892 $ 	1,260 	(29)% 	$ 	484 $ 	542 	(11)% 	$ 	1,751 $ 	1,981 	(12)%
Less: acquisitions 	— 	— 	— 	— 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(31) 	— 	(96) 	— 	(46) 	— 	(132) 	—
Steam Power organic revenues (Non-GAAP) 	$ 	292 $ 	373 	(22)% 	$ 	988 $ 	1,260 	(22)% 	$ 	530 $ 	542 	(2)% 	$ 	1,884 $ 	1,981 	(5)%
Power Conversion, Nuclear and other revenues (GAAP) 	$ 	119 $ 	132 	(10)% 	$ 	385 $ 	555 	(31)% 	$ 	328 $ 	274 	20 % 	$ 	1,162 $ 	1,027 	13 %
Less: acquisitions 	— 	— 	— 	— 	— 	— 	— 	—
Less: business dispositions 	— 	— 	— 	— 	— 	— 	— 	—
Less: foreign currency effect 	(10) 	— 	(27) 	— 	(16) 	— 	(42) 	1
Power Conversion, Nuclear and other organic revenues
(Non-GAAP) 	$ 	129 $ 	131 	(2)% 	$ 	412 $ 	554 	(26)% 	$ 	344 $ 	274 	26 % 	$ 	1,205 $ 	1,027 	17 %
* Non-GAAP Financial Measure
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional
impacts, as these activities can obscure underlying trends.

-- 24 of 39 --

25
Adjusted profit & profit margin
ADJUSTED PROFIT AND PROFIT MARGIN (EXCLUDING CERTAIN ITEMS) (NON-GAAP)
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Total revenues (GAAP) 	$ 	21,786 	$ 	20,303 	7 % 	$ 	76,555 	$ 	74,196 	3 %
Less: Insurance revenues 	775 	811 	2,954 	3,106
Adjusted revenues (Non-GAAP) 	$ 	21,011 	$ 	19,492 	8 % 	$ 	73,602 	$ 	71,090 	4 %
Total costs and expenses (GAAP) 	$ 	21,721 	$ 	24,836 	(13) % 	$ 	76,375 	$ 	80,702 	(5) %
Less: Insurance cost and expenses 	802 	671 	2,894 	2,540
Less: interest and other financial charges 	407 	410 	1,552 	1,813
Less: non-operating benefit cost (income) 	(136) 	408 	(532) 	1,782
Less: restructuring & other 	693 	54 	949 	455
Less: debt extinguishment costs 	465 	5,108 	465 	6,524
Less: separation costs 	419 	— 	973 	—
Less: Steam asset sale impairment 	(1) 	— 	824 	—
Less: Russia and Ukraine charges 	— 	— 	263 	—
Add: noncontrolling interests 	16 	1 	67 	(71)
Add: EFS benefit from taxes 	(53) 	(51) 	(213) 	(162)
Adjusted costs (Non-GAAP) 	$ 	19,035 	$ 	18,135 	5 % 	$ 	68,840 	$ 	67,354 	2 %
Other income (loss) (GAAP) 	$ 	2,172 	$ 	1,066 	F 	$ 	1,231 	$ 	2,823 	(56) %
Less: gains (losses) on equity securities 	1,935 	665 	76 	1,921
Less: restructuring & other 	28 	68 	31 	75
Less: gains (losses) on purchases and sales of business interests 	24 	115 	51 	(44)
Adjusted other income (loss) (Non-GAAP) 	$ 	186 	$ 	218 	(15) % 	$ 	1,074 	$ 	871 	23 %
Profit (loss) (GAAP) 	$ 	2,237 	$ 	(3,467) 	F 	$ 	1,412 	$ 	(3,683) 	F
Profit (loss) margin (GAAP) 	10.3 % 	(17.1) % 	27.4 pts 	1.8 % 	(5.0) % 	6.8 pts
Adjusted profit (loss) (Non-GAAP) 	$ 	2,162 	$ 	1,575 	37 % 	$ 	5,835 	$ 	4,608 	27 %
Adjusted profit (loss) margin (Non-GAAP) 	10.3 % 	8.1 % 	2.2 pts 	7.9 % 	6.5 % 	1.4 pts
* Non-GAAP Financial Measure
We believe that adjusting profit to exclude the effects of items that are not closely associated with ongoing operations provides management and investors with a meaningful measure that increases the period-to-period comparability. Gains (losses) and restructuring and other items are impacted by the
timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities.

-- 25 of 39 --

26
Adjusted profit & profit margin excluding GE HealthCare
ADJUSTED PROFIT AND PROFIT MARGIN (EXCLUDING CERTAIN ITEMS) EXCLUDING
GE HEALTHCARE (NON-GAAP)
(Dollars in millions) 	1Q'22 	2022
Total revenues excluding GE HealthCare (GAAP) 	$ 	12,678 	$ 	58,096
Less: Insurance revenues 	767 	2,954
Adjusted revenues excluding GE HealthCare (Non-GAAP) 	$ 	11,910 	$ 	55,143
Total costs and expenses excluding GE HealthCare (GAAP) 	$ 	13,788 	$ 	60,212
Less: Insurance cost and expenses 	543 	2,894
Less: interest and other financial charges 	371 	1,423
Less: non-operating benefit cost (income) 	(105) 	(409)
Less: restructuring & other 	38 	836
Less: debt extinguishment costs 	— 	465
Less: separation costs 	99 	715
Less: Steam asset sale impairment 	824 	824
Less: Russia and Ukraine charges 	230 	263
Add: noncontrolling interests 	14 	16
Add: EFS benefit from taxes 	(47) 	(213)
Adjusted costs excluding GE HealthCare (Non-GAAP) 	$ 	11,755 	$ 	53,004
Other income (loss) excluding GE HealthCare (GAAP) 	$ 	49 	$ 	1,172
Less: gains (losses) on equity securities 	(219) 	76
Less: restructuring & other 	3 	31
Less: gains (losses) on purchases and sales of business interests 	4 	45
Adjusted other income (loss) excluding GE HealthCare (Non-GAAP) 	$ 	260 	$ 	1,020
Profit (loss) excluding GE HealthCare (GAAP) 	$ 	(1,062) 	$ 	(944)
Profit (loss) margin excluding GE HealthCare (GAAP) 	(8.4) % 	(1.6) %
Adjusted profit (loss) excluding GE HealthCare (Non-GAAP) 	$ 	415 	$ 	3,159
Adjusted profit (loss) margin excluding GE HealthCare (Non-GAAP) 	3.5 % 	5.7 %
* Non-GAAP Financial Measure
We believe that adjusting profit to exclude the effects of items that are not closely associated with ongoing operations provides management and investors with a meaningful measure that increases the period-to-period comparability. Gains (losses) and restructuring and other items are impacted by the
timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a relevant comparison for GE's future results
following the GE HealthCare spin-off in January 2023.

-- 26 of 39 --

27
Adjusted organic profit and profit margin
ADJUSTED ORGANIC PROFIT (NON-GAAP)
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Adjusted profit (loss) (Non-GAAP) 	$ 	2,162 	$ 	1,575 	37 % 	$ 	5,835 	$ 	4,608 	27 %
Less: acquisitions 	2 	(15) 	(72) 	(32)
Less: business dispositions 	— 	1 	— 	14
Less: foreign currency effect 	(139) 	90 	(104) 	70
Adjusted organic profit (loss) (Non-GAAP) 	$ 	2,299 	$ 	1,498 	53 % 	$ 	6,011 	$ 	4,556 	32 %
Adjusted profit (loss) margin (Non-GAAP) 	10.3 % 	8.1 % 	220 bps 	7.9 % 	6.5 % 	140 bps
Adjusted organic profit (loss) margin (Non-GAAP) 	10.6 % 	7.7 % 	290 bps 	8.0 % 	6.4 % 	160 bps
* Non-GAAP Financial Measure
We believe this measure provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, which includes translational and transactional
impacts, as these activities can obscure underlying trends.

-- 27 of 39 --

28
Adjusted earnings (loss) and Adjusted earnings (loss) per share
ADJUSTED EARNINGS (LOSS) (NON-GAAP) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
(Dollars in millions, per-share amounts in dollars) 	Earnings 	EPS 	Earnings 	EPS 	Earnings 	EPS 	Earnings 	EPS 	Earnings 	EPS 	Earnings 	EPS
Earnings (loss) from continuing operations (GAAP) 	$ 	2,178 	1.99 $ (3,561) 	(3.24) 	F 	F $ 	584 	0.53 $ (3,571) 	(3.25) 	F 	F
Insurance earnings (loss) (pre-tax) 	(26) 	(0.02) 	140 	0.13 	65 	0.06 	570 	0.52
Tax effect on Insurance earnings (loss) 	3 	— 	(30) 	(0.03) 	(21) 	(0.02) 	(126) 	(0.11)
Less: Insurance earnings (loss) (net of tax) 	(24) 	(0.02) 	110 	0.10 	44 	0.04 	444 	0.40
Earnings (loss) per share excluding Insurance (Non-GAAP) 	$ 	2,202 	2.01 $ (3,670) 	(3.34) 	F 	F $ 	540 	0.49 $ (4,015) 	(3.66) 	F 	F
Non-operating benefit (cost) income (pre-tax) (GAAP) 	136 	0.12 	(408) 	(0.37) 	532 	0.48 	(1,782) 	(1.62)
Tax effect on non-operating benefit (cost) income 	(29) 	(0.03) 	86 	0.08 	(112) 	(0.10) 	374 	0.34
Less: Non-operating benefit (cost) income (net of tax) 	107 	0.10 	(323) 	(0.29) 	420 	0.38 	(1,408) 	(1.28)
Gains (losses) on purchases and sales of business interests (pre-tax) 	24 	0.02 	115 	0.10 	51 	0.05 	(44) 	(0.04)
Tax effect on gains (losses) on purchases and sales of business interests 	(1) 	— 	(24) 	(0.02) 	67 	0.06 	6 	0.01
Less: Gains (losses) on purchases and sales of business interests (net of tax) 	23 	0.02 	91 	0.08 	118 	0.11 	(37) 	(0.03)
Gains (losses) on equity securities (pre-tax) 	1,935 	1.76 	665 	0.61 	76 	0.07 	1,921 	1.75
Tax effect on gains (losses) on equity securities(a)(b) 	(3) 	— 	(27) 	(0.02) 	(17) 	(0.02) 	128 	0.12
Less: Gains (losses) on equity securities (net of tax) 	1,933 	1.76 	638 	0.58 	58 	0.05 	2,049 	1.87
Restructuring & other (pre-tax) 	(665) 	(0.61) 	14 	0.01 	(918) 	(0.83) 	(380) 	(0.35)
Tax effect on restructuring & other 	145 	0.13 	(1) 	— 	199 	0.18 	35 	0.03
Less: Restructuring & other (net of tax) 	(520) 	(0.47) 	14 	0.01 	(719) 	(0.65) 	(346) 	(0.31)
Debt extinguishment costs (pre-tax) 	(465) 	(0.42) 	(5,108) 	(4.65) 	(465) 	(0.42) 	(6,524) 	(5.94)
Tax effect on debt extinguishment costs 	68 	0.06 	133 	0.12 	68 	0.06 	430 	0.39
Less: Debt extinguishment costs (net of tax) 	(397) 	(0.36) 	(4,975) 	(4.53) 	(397) 	(0.36) 	(6,094) 	(5.55)
Separation costs (pre-tax) 	(419) 	(0.38) 	— 	— 	(973) 	(0.88) 	— 	—
Tax effect on separation costs 	18 	0.02 	— 	— 	77 	0.07 	— 	—
Less: Separation costs (net of tax) 	(401) 	(0.37) 	— 	— 	(896) 	(0.81) 	— 	—
Steam asset sale impairment (pre-tax) 	1 	— 	— 	— 	(824) 	(0.75) 	— 	—
Tax effect on Steam asset sale impairment 	— 	— 	— 	— 	84 	0.08 	— 	—
Less: Steam asset sale impairment (net of tax) 	— 	— 	— 	— 	(740) 	(0.67) 	— 	—
Russia and Ukraine charges (pre-tax) 	— 	— 	— 	— 	(263) 	(0.24) 	— 	—
Tax effect on Russia and Ukraine charges 	— 	— 	— 	— 	15 	0.01 	— 	—
Less: Russia and Ukraine charges (net of tax) 	— 	— 	— 	— 	(248) 	(0.23) 	— 	—
Less: Accretion of redeemable noncontrolling interest (pre-tax and net of tax) 	— 	— 	— 	— 	— 	— 	(9) 	(0.01)
Less: Accretion of preferred share repurchase (pre-tax and net of tax) 	— 	— 	— 	— 	3 	— 	— 	—
Less: U.S. and foreign tax law change enactment 	95 	0.09 	— 	— 	58 	0.05 	8 	0.01
Less: Tax loss related to GECAS transaction 	— 	— 	(11) 	(0.01) 	— 	— 	(54) 	(0.05)
Adjusted earnings (loss) per share (Non-GAAP) 	$ 	1,360 	1.24 	$ 	896 	0.82 	52% 	51% $ 	2,881 	2.62 	$ 	1,876 	1.71 	54% 	53%
* Non-GAAP Financial Measure
(a) Includes tax benefits available to offset the tax on gains in equity securities.
(b) Includes related tax valuation allowances.
Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total.
The service cost for our pension and other benefit plans are included in Adjusted earnings*, which represents the ongoing cost of providing pension benefits to our employees. The components of non-operating benefit costs are mainly driven by capital allocation decisions and market performance. We
believe the retained costs in Adjusted earnings* provides management and investors a useful measure to evaluate the performance of the total company and increases period-to-period comparability.

-- 28 of 39 --

29
Adjusted earnings (loss) and Adjusted earnings (loss) per share excluding
GE HealthCare
ADJUSTED EARNINGS (LOSS) EXCLUDING GE HEALTHCARE (NON-GAAP) 	1Q'22 	2022
(Dollars in millions, per-share amounts in dollars) 	Earnings 	EPS 	Earnings 	EPS
Earnings (loss) from continuing operations excluding GE HealthCare (GAAP) 	$ (1,182) 	(1.07) $ (1,211) 	(1.11)
Insurance earnings (loss) (pre-tax) 	227 	0.21 	65 	0.06
Tax effect on Insurance earnings (loss) 	(49) 	(0.04) 	(21) 	(0.02)
Less: Insurance earnings (loss) (net of tax) 	178 	0.16 	44 	0.04
Earnings (loss) per share excluding Insurance and GE HealthCare (Non-GAAP) $ (1,360) 	(1.24) $ (1,255) 	(1.15)
Non-operating benefit (cost) income (pre-tax) (GAAP) 	105 	0.10 	409 	0.37
Tax effect on non-operating benefit (cost) income 	(22) 	(0.02) 	(86) 	(0.08)
Less: Non-operating benefit (cost) income (net of tax) 	83 	0.08 	323 	0.30
Gains (losses) on purchases and sales of business interests (pre-tax) 	4 	— 	45 	0.04
Tax effect on gains (losses) on purchases and sales of business interests 	(1) 	— 	57 	0.05
Less: Gains (losses) on purchases and sales of business interests (net of tax) 	3 	— 	102 	0.09
Gains (losses) on equity securities (pre-tax) 	(219) 	(0.20) 	76 	0.07
Tax effect on gains (losses) on equity securities(a)(b) 	(20) 	(0.02) 	(17) 	(0.02)
Less: Gains (losses) on equity securities (net of tax) 	(239) 	(0.22) 	58 	0.05
Restructuring & other (pre-tax) 	(35) 	(0.03) 	(806) 	(0.74)
Tax effect on restructuring & other 	8 	0.01 	176 	0.16
Less: Restructuring & other (net of tax) 	(27) 	(0.02) 	(630) 	(0.58)
Debt extinguishment costs (pre-tax) 	— 	— 	(465) 	(0.42)
Tax effect on debt extinguishment costs 	— 	— 	68 	0.06
Less: Debt extinguishment costs (net of tax) 	— 	— 	(397) 	(0.36)
Separation costs (pre-tax) 	(99) 	(0.09) 	(715) 	(0.65)
Tax effect on separation costs 	(24) 	(0.02) 	23 	0.02
Less: Separation costs (net of tax) 	(123) 	(0.11) 	(692) 	(0.63)
Steam asset sale impairment (pre-tax) 	(824) 	(0.75) 	(824) 	(0.75)
Tax effect on Steam asset sale impairment 	84 	0.08 	84 	0.08
Less: Steam asset sale impairment (net of tax) 	(740) 	(0.67) 	(740) 	(0.68)
Russia and Ukraine charges (pre-tax) 	(230) 	(0.21) 	(263) 	(0.24)
Tax effect on Russia and Ukraine charges 	15 	0.01 	15 	0.01
Less: Russia and Ukraine charges (net of tax) 	(215) 	(0.20) 	(248) 	(0.23)
Less: Accretion of preferred share repurchase (pre-tax and net of tax) 	— 	— 	3 	—
Less: U.S. and foreign tax law change enactment 	— 	— 	126 	0.11
Adjusted earnings (loss) per share excluding GE HealthCare (Non-GAAP) 	$ 	(102) 	(0.09) 	$ 	839 	0.77
* Non-GAAP Financial Measure
(a) Includes tax benefits available to offset the tax on gains in equity securities.
(b) Includes related tax valuation allowances.
Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total.
The service cost for our pension and other benefit plans are included in Adjusted earnings*, which represents the ongoing cost of providing pension benefits to our employees. The components of non-operating benefit costs are mainly driven by capital allocation decisions and market performance. We
believe the retained costs in Adjusted earnings* provides management and investors a useful measure to evaluate the performance of the total company and increases period-to-period comparability. We are also presenting these measures excluding the results of GE HealthCare to provide investors
with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023.

-- 29 of 39 --

Adjusted tax rate and Adjusted earnings from continuing operations before income taxes
* Non-GAAP Financial Measure
We believe the retained costs in the Adjusted income tax rate* provides management and investors a useful measure to evaluate the performance of the total company and increases period-to-period comparability.
ADJUSTED TAX RATE (NON-GAAP)
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Earnings (loss) from continuing operations before taxes (GAAP) 	$ 	2,237 	$ 	(3,467) 	$ 	1,412 	$ 	(3,683)
Less: Insurance earnings 	(26) 	140 	65 	570
Earnings (loss) from continuing operations before taxes, excluding Insurance (Non-GAAP) 	$ 	2,263 	$ 	(3,607) 	F 	$ 	1,347 	$ 	(4,252) 	F
Less: non-operating benefit (cost) income 	136 	(408) 	532 	(1,782)
Less: gains (losses) on purchases and sales of business interests 	24 	115 	51 	(44)
Less: gains (losses) on equity securities 	1,935 	665 	76 	1,921
Less: restructuring & other 	(665) 	14 	(918) 	(380)
Less: debt extinguishment costs 	(465) 	(5,108) 	(465) 	(6,524)
Less: separation costs 	(419) 	— 	(973) 	—
Less: Steam asset sale impairment 	1 	— 	(824) 	—
Less: Russia and Ukraine charges 	— 	— 	(263) 	—
Adjusted earnings (loss) from continuing operations before income taxes (Non-GAAP) 	$ 	1,717 	$ 	1,115 	54 % 	$ 	4,131 	$ 	2,558 	61 %
Provision (benefit) for income taxes (GAAP) 	(65) 	37 	476 	(286)
Less: taxes on Insurance earnings 	(3) 	30 	21 	126
Less: taxes on non-operating benefit (cost) income 	29 	(86) 	112 	(374)
Less: taxes on gains (losses) on purchases and sales of business interests 	1 	24 	(67) 	(6)
Less: taxes on gains (losses) on equity securities 	3 	27 	17 	(128)
Less: taxes on restructuring & other 	(145) 	1 	(199) 	(35)
Less: taxes on debt extinguishment costs 	(68) 	(133) 	(68) 	(430)
Less: taxes on separation costs 	(18) 	— 	(77) 	—
Less: taxes on Steam asset sale impairment 	— 	— 	(84) 	—
Less: taxes on Russia and Ukraine charges 	— 	— 	(15) 	—
Less: U.S. and foreign tax law change enactment 	(95) 	— 	(58) 	(8)
Less: tax loss related to GECAS transaction 	— 	11 	— 	54
Adjusted provision (benefit) for income taxes (Non-GAAP) 	$ 	232 	$ 	162 	43 % 	$ 	893 	$ 	516 	73 %
Income tax rate (GAAP) 	(2.9) % 	(1.1) % 	33.7 % 	7.8 %
Adjusted income tax rate (Non-GAAP) 	13.5 % 	14.5 % 	21.6 % 	20.2 %
ADJUSTED EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Adjusted profit (loss) (Non-GAAP) 	$ 	2,162 	$ 	1,575 	37 % 	$ 	5,835 	$ 	4,608 	27 %
Add: interest and other financial charges (ex EFS, ex Insurance) 	(408) 	(410) 	(1,558) 	(1,817)
Less: noncontrolling interests 	(16) 	(1) 	(67) 	71
Less: EFS benefit from taxes 	53 	51 	213 	162
Adjusted earnings (loss) from continuing operations before income taxes (Non-GAAP) 	$ 	1,717 	$ 	1,115 	54 % 	$ 	4,131 	$ 	2,558 	61 % 	30

-- 30 of 39 --

FREE CASH FLOWS (FCF) (NON-GAAP)
(Dollars in millions) 	4Q'22 	4Q'21 	V$ 	2022 	2021 	V$
CFOA (GAAP) 	$ 	4,571 $ 	2,415 $ 	2,156 $ 	5,864 $ 	888 $ 	4,976
Less: Insurance CFOA 	88 	46 	136 	86
CFOA excluding Insurance (Non-GAAP) 	$ 	4,483 $ 	2,369 $ 	2,114 $ 	5,728 $ 	802 $ 	4,926
Add: gross additions to property, plant and equipment(a) 	(414) 	(355) 	(1,371) 	(1,250)
Add: gross additions to internal-use software(a) 	(35) 	(33) 	(113) 	(111)
Less: separation cash expenditures 	(143) 	— 	(261) 	—
Less: Corporate restructuring cash expenditures 	(38) 	— 	(38) 	—
Less: taxes related to business sales 	(71) 	— 	(214) 	(6)
Less: CFOA impact from factoring programs discontinued in 2021 	— 	(2,041) 	— 	(5,108)
Less: CFOA impact from receivables factoring and supply chain finance eliminations 	— 	314 	— 	2,666
Free cash flows (Non-GAAP) 	$ 	4,286 $ 	3,708 $ 	578 $ 	4,758 $ 	1,889 $ 	2,869
Less: prior period CFOA impact from factoring programs discontinued in 2021(b) 	— 	— 	— 	(739)
Free cash flows excluding discontinued factoring (Non-GAAP) 	$ 	4,286 $ 	3,708 $ 	578 $ 	4,758 $ 	2,628 $ 	2,130
FREE CASH FLOWS (FCF) EXCLUDING GE HEALTHCARE (NON-GAAP)
(Dollars in millions) 	1Q'22 	2022
CFOA excluding GE HealthCare (GAAP) 	$ 	(924) $ 	4,023
Less: Insurance CFOA 	(15) 	136
CFOA excluding Insurance and GE HealthCare (Non-GAAP) 	$ 	(909) $ 	3,887
Add: gross additions to property, plant and equipment(a) 	(239) 	(1,061)
Add: gross additions to internal-use software(a) 	(22) 	(113)
Less: separation cash expenditures 	(3) 	(178)
Less: Corporate restructuring cash expenditures 	— 	(38)
Less: taxes related to business sales 	— 	(129)
Free cash flows excluding GE HealthCare (Non-GAAP) 	$ 	(1,169) $ 	3,059
31
Free cash flows (FCF) (including and excluding discontinued factoring) and Free cash
flows (FCF) excluding GE HealthCare
* Non-GAAP Financial Measure
(a) Included in Gross CAPEX
(b) Represents the CFOA impact from cash that GE would have otherwise collected had customer receivables not been previously sold in factoring programs that have now been discontinued.
We believe investors may find it useful to compare free cash flows* performance without the effects of CFOA related to our run-off Insurance business, separation cash expenditures, Corporate restructuring cash expenditures (associated with the separation-related program announced in October, 2022), taxes related
to business sales and eliminations related to our receivables factoring and supply chain finance programs. We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flows. The CFOA impact from receivables factoring and supply chain finance
eliminations represents activity related to those internal programs previously facilitated for our industrial segments by our Working Capital Solutions business. We completed the exit from all internal factoring and supply chain finance programs in 2021. We are also presenting these measures excluding the results of
GE HealthCare to provide investors with a relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023.

-- 31 of 39 --

32
Free cash flows (FCF) by quarter (including and excluding discontinued factoring)
FREE CASH FLOWS (FCF) (NON-GAAP)
(Dollars in millions) 	1Q'22 	2Q'22 	3Q'22 	4Q'22 	2022
CFOA (GAAP) 	$ 	(535) $ 	508 $ 	1,320 $ 	4,571 $ 	5,864
Less: CFOA from insurance 	(15) 	70 	(7) 	88 	136
CFOA excluding Insurance (Non-GAAP) 	$ 	(520) $ 	438 $ 	1,328 $ 	4,483 $ 	5,728
Add: gross additions to property, plant and equipment(a) 	(340) 	(320) 	(297) 	(414) 	(1,371)
Add: gross additions to internal-use software(a) 	(23) 	(26) 	(30) 	(35) 	(113)
Less: separation cash expenditures 	(3) 	(20) 	(96) 	(143) 	(261)
Less: Corporate restructuring cash expenditures 	— 	— 	— 	(38) 	(38)
Less: taxes related to business sales 	— 	(50) 	(93) 	(71) 	(214)
Free cash flows (Non-GAAP) 	$ 	(880) $ 	162 $ 	1,189 $ 	4,286 $ 	4,758
Less: prior period CFOA impact from factoring programs discontinued in 2021(b) 	— 	— 	— 	— 	—
Free cash flows excluding discontinued factoring (Non-GAAP) 	$ 	(880) $ 	162 $ 	1,189 $ 	4,286 $ 	4,758
FREE CASH FLOWS (FCF) (NON-GAAP)
(Dollars in millions) 	1Q'21 	2Q'21 	3Q'21 	4Q'21 	2021
CFOA (GAAP) 	$ 	(2,640) $ 	(351) $ 	1,464 $ 	2,415 $ 	888
Less: CFOA from insurance 	60 	(16) 	(4) 	46 	86
CFOA excluding Insurance (Non-GAAP) 	$ 	(2,699) $ 	(336) $ 	1,467 $ 	2,369 $ 	802
Add: gross additions to property, plant and equipment(a) 	(332) 	(267) 	(296) 	(355) 	(1,250)
Add: gross additions to internal-use software(a) 	(24) 	(26) 	(29) 	(33) 	(111)
Less: CFOA impact from factoring programs discontinued in 2021 	— 	(2,706) 	(362) 	(2,041) 	(5,108)
Less: CFOA impact from receivables factoring and supply chain finance eliminations 	306 	1,884 	161 	314 	2,666
Less: taxes related to business sales 	— 	(6) 	— 	— 	(6)
Free cash flows (Non-GAAP) 	$ 	(3,361) $ 	199 $ 	1,343 $ 	3,708 $ 	1,889
Less: prior period CFOA impact from factoring programs discontinued in 2021(b) 	(778) 	67 	(28) 	— 	(739)
Free cash flows excluding discontinued factoring (Non-GAAP) 	$ 	(2,583) $ 	132 $ 	1,371 $ 	3,708 $ 	2,628
* Non-GAAP Financial Measure
(a) Included in Gross CAPEX
(b) Represents the CFOA impact from cash that GE would have otherwise collected had customer receivables not been previously sold in factoring programs that have now been discontinued.
We believe investors may find it useful to compare free cash flows* performance without the effects of CFOA related to our run-off Insurance business, separation cash expenditures, Corporate restructuring cash expenditures (associated with the separation-related program announced in October, 2022), taxes related
to business sales and eliminations related to our receivables factoring and supply chain finance programs. We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flows. The CFOA impact from receivables factoring and supply chain finance
eliminations represents activity related to those internal programs previously facilitated for our industrial segments by our Working Capital Solutions business. We completed the exit from all internal factoring and supply chain finance programs in 2021.

-- 32 of 39 --

33
Free cash flows (FCF) by segment (including and excluding discontinued factoring)
2022 FREE CASH FLOWS (FCF) (Non-GAAP)
(Dollars in millions) 	Aerospace 	Renewables 	Power 	HealthCare 	Corporate 	Total Company
CFOA (GAAP) 	$ 	5,514 $ 	(1,759) $ 	2,078 $ 	2,435 $ 	(2,404) $ 	5,864
Less: Insurance CFOA 	— 	— 	— 	— 	136 	136
CFOA excluding Insurance (Non-GAAP) 	$ 	5,514 $ 	(1,759) $ 	2,078 $ 	2,435 $ 	(2,540) $ 	5,728
Add: gross additions to property, plant and equipment(a) 	(543) 	(275) 	(210) 	(310) 	(34) 	(1,371)
Add: gross additions to internal-use software(a) 	(81) 	(7) 	(18) 	— 	(7) 	(113)
Less: separation cash expenditures 	— 	— 	— 	— 	(261) 	(261)
Less: Corporate restructuring cash expenditures 	— 	— 	— 	— 	(38) 	(38)
Less: taxes related to business sales 	— 	— 	— 	— 	(214) 	(214)
Free cash flows (Non-GAAP) 	$ 	4,890 $ 	(2,040) $ 	1,850 $ 	2,125 $ 	(2,068) $ 	4,758
Less: prior period CFOA impact from factoring programs discontinued in 2021(b) 	— 	— 	— 	— 	— 	—
Free cash flows excluding discontinued factoring (Non-GAAP) 	$ 	4,890 $ 	(2,040) $ 	1,850 $ 	2,125 $ 	(2,068) $ 	4,758
2021 FREE CASH FLOWS (FCF) (Non-GAAP)
(Dollars in millions) 	Aerospace 	Renewables 	Power 	HealthCare 	Corporate 	Total Company
CFOA (GAAP) 	$ 	2,815 $ 	(1,576) $ 	24 $ 	1,471 $ 	(1,846) $ 	888
Less: Insurance CFOA 	— 	— 	— 	— 	86 	86
CFOA excluding Insurance (Non-GAAP) 	$ 	2,815 $ 	(1,576) $ 	24 $ 	1,471 $ 	(1,933) $ 	802
Add: gross additions to property, plant and equipment(a) 	(445) 	(349) 	(189) 	(242) 	(25) 	(1,250)
Add: gross additions to internal-use software(a) 	(61) 	(9) 	(23) 	(6) 	(13) 	(111)
Less: CFOA impact from factoring programs discontinued in 2021 	(2,006) 	(539) 	(1,117) 	(1,481) 	35 	(5,108)
Less: CFOA impact from receivables factoring and supply chain finance eliminations 	— 	— 	— 	— 	2,666 	2,666
Less: taxes related to business sales 	— 	— 	— 	— 	(6) 	(6)
Free cash flows (Non-GAAP) 	$ 	4,315 $ 	(1,395) $ 	929 $ 	2,705 $ 	(4,665) $ 	1,889
Less: prior period CFOA impact from factoring programs discontinued in 2021(b) 	(314) 	(195) 	(232) 	— 	2 	(739)
Free cash flows excluding discontinued factoring (Non-GAAP) 	$ 	4,629 $ 	(1,200) $ 	1,161 $ 	2,705 $ 	(4,667) $ 	2,628
* Non-GAAP Financial Measure
(a) Included in Gross CAPEX
(b) Represents the CFOA impact from cash that GE would have otherwise collected had customer receivables not been previously sold in factoring programs that have now been discontinued.
We believe investors may find it useful to compare free cash flows* performance without the effects of CFOA related to our run-off Insurance business, separation cash expenditures, Corporate restructuring cash expenditures (associated with the separation-related program announced in October, 2022), taxes related
to business sales and eliminations related to our receivables factoring and supply chain finance programs. We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flows. The CFOA impact from receivables factoring and supply chain finance
eliminations represents activity related to those internal programs previously facilitated for our industrial segments by our Working Capital Solutions business. We completed the exit from all internal factoring and supply chain finance programs in 2021.

-- 33 of 39 --

Adjusted Corporate costs
34
CORPORATE REVENUES AND PROFIT (COST)
(Dollars in millions) 	4Q'22 	4Q'21 	V% 	2022 	2021 	V%
Corporate revenues 	$ 	247 $ 	253 	$ 	882 $ 	945
Insurance revenues 	775 	811 	2,954 	3,106
Eliminations and other 	(260) 	(319) 	(1,030) 	(1,490)
Total Corporate revenues 	$ 	762 $ 	745 	2 % $ 	2,806 $ 	2,561 	10 %
Gains (losses) on purchases and sales of business interests 	$ 	24 $ 	115 	$ 	51 $ 	(44)
Gains (losses) on equity securities 	1,935 	665 	76 	1,921
Restructuring and other charges 	(665) 	14 	(918) 	(380)
Separation costs 	(419) 	— 	(973) 	—
Steam asset sale impairment 	1 	— 	(824) 	—
Russia and Ukraine charges 	— 	— 	(263) 	—
Insurance profit (loss) 	(27) 	140 	60 	566
Adjusted total Corporate operating costs (Non-GAAP) 	(314) 	(403) 	(621) 	(1,170)
Total Corporate operating profit (cost) (GAAP) 	$ 	533 $ 	531 	$ 	(3,413) $ 	892
Less: gains (losses), impairments, Insurance, and restructuring & other 	848 	934 	(2,792) 	2,062
Adjusted total Corporate operating costs (Non-GAAP) 	$ 	(314) $ 	(403) 	22 % $ 	(621) $ 	(1,170) 	47 %
Functions & operations 	$ 	(310) $ 	(307) 	$ 	(568) $ 	(848)
Environmental, health and safety (EHS) and other items 	(14) 	(118) 	(94) 	(302)
Eliminations 	9 	22 	41 	(20)
Adjusted total Corporate operating costs (Non-GAAP) 	$ 	(314) $ 	(403) 	22 % $ 	(621) $ 	(1,170) 	47 %
* Non-GAAP Financial Measure
Adjusted total Corporate operating costs* excludes gains (losses) on purchases and sales of business interests, significant, higher-cost restructuring programs, separation costs, gains (losses) on equity securities, impairments and our run-off Insurance business profit. We believe that adjusting
Corporate costs to exclude the effects of items that are not closely associated with ongoing Corporate operations provides management and investors with a meaningful measure that increases the period-to-period comparability of our ongoing Corporate costs.

-- 34 of 39 --

GE, including GE HealthCare - net debt
35
* Non-GAAP Financial Measure
(a) We are including this calculation to provide another market view to GE’s leverage.
(b) Represents the total net deficit status of principal pension plans, other pension plans and retiree benefit plans.
(c) We are including this calculation to provide a view aligned to credit rating methodology.
Market Aligned Approach
• 	Measure introduced in 4Q’21 to provide
another market view to GE’s leverage.
Rating Agency Aligned Approach
• 	Measure introduced in 2018. Aligned to credit
rating methodology.
NET DEBT (NON-GAAP)
(Dollars in millions) 	December 31, 2022
Total consolidated GE borrowings (GAAP) 	32,350
100% of preferred stock 	5,795
Deduction for 100% of GE cash, cash equivalents and restricted cash 	(17,262)
Total GE consolidated net debt - market aligned (Non-GAAP)(a) 	20,884
NET DEBT (NON-GAAP)
(Dollars in millions) 	December 31, 2022
Total consolidated GE borrowings (GAAP) 	32,350
Pension and principal retiree benefit plan liabilities (pre-tax)(b) 	11,145
Less: taxes at 21% 	2,340
Pension and principal retiree benefit plan liabilities (net of tax) 	8,805
GE operating lease liabilities 	2,393
GE Industrial preferred stock 	5,795
Less: 50% of GE preferred stock 	2,897
50% GE preferred stock 	2,897
Short-term off-book factoring 	100
Deduction for GE cash, cash equivalents and restricted cash 	17,262
Less: 25% of GE cash, cash equivalents, and restricted cash 	(4,315)
Deduction for 75% of GE cash, cash equivalents and restricted cash 	(12,946)
Total GE consolidated net debt - (Non-GAAP)(c) 	33,599

-- 35 of 39 --

GE, excluding GE HealthCare - net debt
36
* Non-GAAP Financial Measure
(a) Assumes $1,451MM of cash on GE HealthCare’s books as of 12/31.
(b) We are including this calculation to provide another market view to GE’s leverage. We are also presenting this measure excluding the net debt of GE HealthCare to provide investors with a relevant comparison for GE's future net debt following the GE HealthCare spin-off in January 2023.
(c) Of the $2,000MM term loan that GE HealthCare drew down on January 3, 2023, GE HealthCare retained $349MM (to begin its operations with cash of $1,800MM). GE HealthCare distributed to GE the remaining $1,651MM of the draw down.
(d) Represents the total net deficit status of principal pension plans, other pension plans and retiree benefit plans.
(e) We are including this calculation to provide a view aligned to credit rating methodology. We are also presenting this measure excluding the net debt of GE HealthCare to provide investors with a relevant comparison for GE's future net debt following the GE HealthCare spin-off in January 2023.
Market Aligned Approach
• 	Measure introduced in 4Q’21 to provide
another market view to GE’s leverage.
Rating Agency Aligned Approach
• 	Measure introduced in 2018. Aligned to credit
rating methodology.
NET DEBT (NON-GAAP) excluding GE
HealthCare	(Dollars in millions)
Total consolidated GE borrowings (GAAP) 	24,059
100% of preferred stock 	5,795
Deduction for 100% of GE cash, cash equivalents and restricted cash(a) 	(15,810)
Total GE excluding GE HealthCare net debt - (Non-GAAP)(b) 	14,044
Cash Distribution from GE HealthCare after drawing term loan on 1/3/23(c) 	(1,651)
Total GE excluding GE HealthCare net debt - (Non-GAAP) with term loan(b) 	12,392
NET DEBT (NON-GAAP) excluding GE
HealthCare	(Dollars in millions)
Total consolidated GE borrowings (GAAP) 	24,059
Pension and principal retiree benefit plan liabilities (pre-tax)(d) 	6,923
Less: taxes at 21% 	1,454
Pension and principal retiree benefit plan liabilities (net of tax) 	5,469
GE operating lease liabilities 	2,106
GE Industrial preferred stock 	5,795
Less: 50% of GE preferred stock 	2,897
50% GE preferred stock 	2,897
Short-term off-book factoring 	98
Deduction for GE cash, cash equivalents and restricted cash(a) 	15,810
Less: 25% of GE cash, cash equivalents, and restricted cash 	(3,953)
Deduction for 75% of GE cash, cash equivalents and restricted cash 	(11,858)
Total GE excluding GE HealthCare net debt - (Non-GAAP)(e) 	22,772
75% of Cash Distribution from GE HealthCare after drawing term loan on 1/3/23(c) 	(1,238)
Total GE excluding GE HealthCare net debt - (Non-GAAP) with term loan(e) 	21,533

-- 36 of 39 --

GE, including GE HealthCare - EBITDA & leverage
* Non-GAAP Financial Measure
(a) Other items are mainly comprised of adjustments for gains and out of segment restructuring
(b) Rating Agency aligned adjustments are mainly comprised of adjusted other income, long-term fixed operating lease expense, stock-related compensation expense and out of segment restructuring that is not related to the GE HealthCare separation.
We believe that providing both rating agency aligned leverage and market aligned leverage provides management and investors with useful measures to evaluate company leverage and debt.
37
GE LEVERAGE (NON-GAAP)
(Dollars in millions) 	December 31, 2022
GE earnings (loss) from continuing operations before income taxes (GAAP) 	1,412
Less: Insurance earnings before income taxes 	60
Less: Interest and other financial charges 	(1,552)
Less: Non-operating benefit costs 	532
Less: Restructuring & other(a) 	(724)
Less: Debt extinguishment costs 	(465)
Less: Separation costs 	(973)
Less: Russia and Ukraine charges 	(263)
Add: EFS benefit from taxes 	213
Less: Depreciation and amortization of property, plant and equipment and amortization of intangible assets 	(3,544)
Total GE leverage EBITDA - MARKET ALIGNED (Non-GAAP) 	8,555
Add: Rating Agency aligned adjustments(b) 	(94)
Total GE leverage EBITDA - RATING AGENCY ALIGNED (Non-GAAP) 	8,460
GE NET DEBT / EBITDA RATIO - MARKET ALIGNED (NON-GAAP) 	GE NET DEBT/EBITDA RATIO - RATING AGENCY ALIGNED (NON-GAAP)
(Dollars in millions) 	December 31, 2022 	(Dollars in millions) 	December 31, 2022
Net Debt - market aligned (Non-GAAP) 	20,884 	Net Debt - Rating Agency aligned (Non-GAAP) 	33,599
Total GE leverage EBITDA - market aligned (Non-GAAP) 	8,555 	Total GE leverage EBITDA - Rating Agency aligned (Non-GAAP) 	8,460
GE net debt/EBITDA ratio - market aligned (Non-GAAP) 	2.4x 	GE net debt/EBITDA ratio - Rating Agency aligned (Non-GAAP) 	4.0x
Approaches
• 	Market Aligned: Measure introduced in 4Q’21 to provide another market view to GE’s leverage.
• 	Rating Agency Aligned: Measure introduced in 2018. Aligned to credit rating methodology.

-- 37 of 39 --

GE, excluding GE HealthCare - EBITDA & leverage
* Non-GAAP Financial Measure
(a) Other items are mainly comprised of adjustments for gains and out of segment restructuring
(b) Rating Agency aligned adjustments are mainly comprised of adjusted other income, long-term fixed operating lease expense, stock-related compensation expense and out of segment restructuring that is not related to the GE HealthCare separation.
(c) Includes the benefit of a cash distribution received from GE HealthCare, in connection with the draw of the term loan, as part of the spin on January 3, 2023.
We believe that providing both rating agency aligned leverage and market aligned leverage provides management and investors with useful measures to evaluate company leverage and debt. We are also presenting these measures excluding the results of GE HealthCare to provide investors with a
relevant comparison for GE's future results following the GE HealthCare spin-off in January 2023.
38
GE LEVERAGE (NON-GAAP) excluding GE
HealthCare	(Dollars in millions)
GE earnings (loss) excluding GE HealthCare from continuing operations before income taxes (GAAP) 	(944)
Less: Insurance earnings before income taxes 	60
Less: Interest and other financial charges 	(1,423)
Less: Non-operating benefit costs 	409
Less: Restructuring & other(a) 	(668)
Less: Debt extinguishment costs 	(465)
Less: Separation costs 	(715)
Less: Russia and Ukraine charges 	(263)
Add: EFS benefit from taxes 	213
Less: Depreciation and amortization of property, plant and equipment and amortization of intangible assets 	(2,904)
Total GE leverage EBITDA excluding GE HealthCare - MARKET ALIGNED (Non-GAAP) 	5,238
Add: Rating Agency aligned adjustments(b) 	(170)
Total GE leverage EBITDA excluding GE HealthCare - RATING AGENCY ALIGNED (Non-GAAP) 	5,068
GE NET DEBT / EBITDA RATIO - MARKET ALIGNED (NON-GAAP) excluding GE
HealthCare(c)
GE NET DEBT/EBITDA RATIO - RATING AGENCY ALIGNED (NON-GAAP) excluding GE
HealthCare(c)	(Dollars in millions) 	(Dollars in millions)
Net Debt - market aligned (Non-GAAP) 	12,392 	Net Debt - Rating Agency aligned (Non-GAAP) 	21,533
Total GE leverage EBITDA - market aligned (Non-GAAP) 	5,238 	Total GE leverage EBITDA - Rating Agency aligned (Non-GAAP) 	5,068
GE net debt/EBITDA ratio - market aligned (Non-GAAP) 	2.4x 	GE net debt/EBITDA ratio - Rating Agency aligned (Non-GAAP) 	4.2x
Approaches
• 	Market Aligned: Measure introduced in 4Q’21 to provide another market view to GE’s leverage.
• 	Rating Agency Aligned: Measure introduced in 2018. Aligned to credit rating methodology.

-- 38 of 39 --

Upcoming calendar
2023 GE Investor Conference 	March 9, 2023
1Q'23 earnings 	April 25, 2023
Annual Shareholders Meeting 	May 3, 2023
2Q'23 earnings 	July 25, 2023
3Q'23 earnings 	October 24, 2023
4Q'23 earnings 	January 23, 2024
39

-- 39 of 39 --